
Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL
The HemOnc Pulse
00:00
Comparing Side Effects and Quality of Life Impact of Novel Therapy in DLBCL
Exploration of the side effects and accessibility of a novel therapy compared to CAR-T therapy. Focus on lower-grade CRS, step-up dosing strategy for risk management, and enhanced accessibility in community sites for improved quality of life.
Transcript
Play full episode